CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND ARE THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL AND HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE...License Agreement • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks • California
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis License Agreement (this “Agreement”) is dated as of October 17, 2024 (the “Effective Date”) by and between Bala Therapeutics, Inc., a corporation organized under Delaware law, (“Licensor”), and Lomond Therapeutics, Inc., a corporation organized under Delaware law (“Company”). Licensor and Company may be referred to herein as a “Party” or, collectively, as “Parties.”
LICENSE AGREEMENTLicense Agreement • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks • California
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis License Agreement (this “Agreement”) is dated as of October 17, 2024 (the “Effective Date”) by and between Eil Therapeutics, Inc., a corporation organized under Delaware law, (“Licensor”), and Lomond Therapeutics, Inc., a corporation organized under Delaware law (“Company”). Licensor and Company may be referred to herein as a “Party” or, collectively, as “Parties.”